<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00004406</url>
  </required_header>
  <id_info>
    <org_study_id>199/13293</org_study_id>
    <secondary_id>CPS-CU-FDR001024</secondary_id>
    <nct_id>NCT00004406</nct_id>
  </id_info>
  <brief_title>Randomized Study of Human Parathyroid Hormone in Middle-Aged Men With Idiopathic Osteoporosis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>FDA Office of Orphan Products Development</source>
  <brief_summary>
    <textblock>
      OBJECTIVES:

      I. Determine the effect of human parathyroid hormone (1-34) on bone mass in middle-aged men
      with idiopathic osteoporosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PROTOCOL OUTLINE: This is a randomized, double blind, placebo controlled study. All patients
      self-administer daily subcutaneous injections of human parathyroid hormone (1-34) or placebo
      for a period of 2.5 years.

      Patients are followed regularly for unacceptable toxicities.

      Completion date provided represents the completion date of the grant per OOPD records
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 1999</start_date>
  <completion_date>July 2004</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Osteoporosis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>human parathyroid hormone</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        PROTOCOL ENTRY CRITERIA:

        --Disease Characteristics--

        Osteoporosis as defined by: Bone mineral density at the lumbar spine or femoral neck that
        is 2.5 standard deviations below peak bone mass reference value (T score less than -2.5)

        No family history of male osteoporosis

        No other metabolic bone disease

        --Prior/Concurrent Therapy--

        Endocrine therapy:

          -  No concurrent glucocorticoid therapy

          -  No prior steroid use

        Surgery: No prior gastrointestinal tract surgery

        Other: No prior or concurrent anticonvulsant therapy

        --Patient Characteristics--

        Hematopoietic: Normal CBC

        Hepatic: Normal liver function

        Renal: Normal renal function

        Other:

          -  Normal thyroid function

          -  Normal adrenal function

          -  Normal gonadal status

          -  No myeloma or other malignancy

          -  No alcoholism, hypercortisolism or diabetes mellitus

          -  No gastrointestinal tract disease or disorder associated with malabsorption
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>29 Years</minimum_age>
    <maximum_age>67 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Paul Bilezikian</last_name>
    <role>Study Chair</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Columbia University College of Physicians and Surgeons</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2000</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 1999</study_first_submitted>
  <study_first_submitted_qc>October 18, 1999</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 1999</study_first_posted>
  <last_update_submitted>March 24, 2015</last_update_submitted>
  <last_update_submitted_qc>March 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 25, 2015</last_update_posted>
  <keyword>disease-related problem/condition</keyword>
  <keyword>osteoporosis</keyword>
  <keyword>rare disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

